InvestSMART

Carnegie Clean Energy Limited (ASX: CCE) - Announcements

Current share price for CCE : $0.225 0.02 (9.76%)+

ASX company news and announcements for Carnegie Clean Energy Limited (CCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Carnegie Clean Energy Limited (CCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Carnegie Clean Energy Limited (CCE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Carnegie Clean Energy Limited (CCE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$93 Preliminary Final Report 1 Sep 2005 8:30AM $0.360 $0.225 fallen by 37.50%
$93 Disclosure Document 17 Aug 2005 8:30AM $0.380 $0.225 fallen by 40.79%
$93 Completes Capital Raising 11 Aug 2005 9:21AM $0.380 $0.225 fallen by 40.79%
$93 Trading Halt 9 Aug 2005 9:47AM n/a $0.225 n/a
$93 Commitments Test Entity - Fourth Quarter Report 28 Jul 2005 8:30AM $0.380 $0.225 fallen by 40.79%
$93 First CellSpray XP Patient Treated 26 Jul 2005 8:29AM $0.375 $0.225 fallen by 40%
$93 ISO Re-certification 24 Feb 2005 8:32AM $0.410 $0.225 fallen by 45.12%
$93 Disclosure Document 25 Jan 2005 8:36AM $0.375 $0.225 fallen by 40%
$93 EpiGrow Product Development Agreement 18 Jan 2005 8:31AM $0.375 $0.225 fallen by 40%
$93 C3 Achieves Breakthrough - Recell Approval in Japan 16 Dec 2004 8:30AM $0.400 $0.225 fallen by 43.75%
$93 Reinstatement to Official Quotation 7 Dec 2004 12:45PM $0.340 $0.225 fallen by 33.82%
$93 Suspension from Official Quotation 26 Nov 2004 10:02AM n/a $0.225 n/a
$93 Trading Halt 24 Nov 2004 3:29PM $0.330 $0.225 fallen by 31.82%
$93 Appoint 6 New Distributors/CellSpray Authorisation-Denmark 20 Sep 2004 11:22AM $0.490 $0.225 fallen by 54.08%
$93 Japanese Revenues & Distributor Agreement 7 Sep 2004 11:30AM $0.480 $0.225 fallen by 53.13%
$93 CellSpray approved for use in the UK 27 Aug 2004 8:30AM $0.465 $0.225 fallen by 51.61%
$93 Trading Halt 3 Aug 2004 3:05PM $0.470 $0.225 fallen by 52.13%
$93 C3 Receives GMP Approval 6 Jul 2004 10:04AM $0.540 $0.225 fallen by 58.33%
$93 Cellspray XP receives Swiss Approval 30 Mar 2004 10:19AM $0.490 $0.225 fallen by 54.08%
$93 Media Release/Half Yearly Report/Half Year Accounts 19 Feb 2004 11:08AM $0.510 $0.225 fallen by 55.88%
$93 Cellspray to be Used in the Netherlands & Denmark 13 Feb 2004 11:07AM $0.500 $0.225 fallen by 55%
$93 Cellspray receives European Approvals 9 Jan 2004 1:05PM $0.435 $0.225 fallen by 48.28%
$93 Cellspray receives European Approvals 9 Jan 2004 1:05PM $0.435 $0.225 fallen by 48.28%
$93 C3 Secures Australia/New Zealand Distribution Partner 24 Oct 2003 10:32AM $0.330 $0.225 fallen by 31.82%
$93 Preliminary Final Report 12 Sep 2003 1:45PM $0.420 $0.225 fallen by 46.43%

601 - 625 of 627 results

Page 25 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.